GoodRx Holdings (GDRX) shares have slipped about 27% over the past month, drawing investor attention to recent performance trends. The company’s ongoing path sparks questions about how current ...
Investing.com -- GoodRx (NASDAQ:GDRX) stock fell 5% on Thursday after a CBS reporter indicated that the discount prescription drug platform would not be partnering with the upcoming TrumpRx initiative ...
GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 12 Best American Penny Stocks to Buy Right Now. On November 6, Goldman ...
StockStory.org on MSN
GoodRx’s (NASDAQ:GDRX) Q3 Sales Top Estimates
Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q3 CY2025 results , but sales were flat year on year at $196 million.
The medication savings platform GoodRx hopes to partner with the Trump administration on TrumpRx, the government’s planned drug-buying website.
Zacks.com on MSN
GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings Estimates
GoodRx (GDRX) delivered earnings and revenue surprises of -11.11% and +1.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
GoodRx Holdings, Inc. ( GDRX) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Third Quarter 2025 Earnings Call. As a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback